Healthcare and Pharmaceuticals industry

Global Cephalosporin Market Size Share Forecast 2024




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

In the world economic growth, the Cephalosporin Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Cephalosporin market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Cephalosporin market size will be further expanded, we expect that by 2024, The market size of the Cephalosporin will reach XXX million $.

The cephalosporins are a class of β-lactam antibiotics originally derived from the fungus Acremonium. Cephalosporins are used for the treatment of infections caused by susceptible bacteria such as bone infections, ear infections, skin infections, upper respiratory tract infections, and urinary tract infections. There are different types of cephalosporins that include, first-generation cephalosporins, second-generation cephalosporins, third-generation cephalosporins, fourth-generation cephalosporins, and fifth-generation cephalosporins.

Long half-life of third-generation cephalosporins is expected to propel growth of the global cephalosporins market over the forecast period. For instance, ceftriaxone, a third-generation cephalosporin, has a long half-life which allows for once-daily dosing and is used for the treatment of gonorrhea, pelvic inflammatory disease, and epididymo-orchitis. Moreover, increasing the incidence of gonorrhea is also expected to aid in growth of the market. For instance, according to the Centers for Disease Control and Prevention, the rate of reported gonorrhea cases increased 5.0%, and increased 82.6% during 2017–2018 and a total of 583,405 cases of gonorrhea were reported in the U.S. in 2018.

Increasing the prevalence of otitis media is expected to boost growth of the global cephalosporins market. For instance, according to the study, “Prevalence of chronic suppurative otitis media in schoolgoing children”, published in 2018, in the Indian Journal of Otology, the prevalence of chronic suppurative otitis media in urban school children was 2.32%, while for rural children, it was 5.11%.

However, the use of cephalosporins can lead to some side effects such as abdominal pain, diarrhea, dyspepsia, headache, gastritis, and nausea vomiting, and transient liver problems, which are expected to hinder growth of the global cephalosporins market to some extent.

Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in March 2020, ADVANZ PHARMA Corp. Limited, a global pharmaceutical company, entered into an arrangement to acquire outstanding shares of Correvio Pharma Corp., specialty pharmaceutical company and developer of Zevtera/Mabelio (ceftobiprole medocaril sodium), a cephalosporin antibiotic for the treatment of community- and hospital-acquired pneumonia.

Major players in the market are also focused on conducting clinical trials to expand their product portfolio. For instance, in February 2020, Allecra Therapeutics, a France-based pharmaceutical company, announced that its Exblifep (cefepime-enmetazobactam), a combination of a novel extended-spectrum beta-lactamase inhibitor, enmetazobactam, and the fourth-generation cephalosporin cefepime, achieved primary endpoints in a clinical trial for complicated urinary tract infections (cUTI).

Key Takeaways:

  • Increasing prevalence of otitis media to augment growth of the global cephalosporins market
  • Major players operating in the global cephalosporins market include, Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, Hospira, Dhanuka Laboratories, Fukang, Dongying Pharmaceutical, Alkem, SALUBRIS, LIVZON, Hetero Drugs, CSPC, Teva Pharmaceuticals, ADVANZ PHARMA Corp. Limited, Orchid Pharma, Taj Pharmaceuticals, Covalent Laboratories, United Laboratories, Aurobindo, Wockhardt, LKPC, HPGC, and Huafangpharm

This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. It also covers different industries ' client's information, which is very important for the manufacturers. If you need more information, please contact SMI

Section 1: Definition

Section (2 3): Manufacturer Detail

Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm

Section 4: Region Segmentation

North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)

Section (5 6 7): Segmentation

Product Type Segmentation:

First Generation
Second Generation
Third Generation
Fourth Generation

Industry Segmentation:

Oral
Injection

Channel (Direct Sales, Distributor) Segmentation

Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion

Table of Contents

Section 1 Cephalosporin Product Definition

Section 2 Global Cephalosporin Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Cephalosporin Shipments
2.2 Global Manufacturer Cephalosporin Business Revenue
2.3 Global Cephalosporin Market Overview

Section 3 Manufacturer Cephalosporin Business Introduction
3.1 Union Chempharma Cephalosporin Business Introduction
3.1.1 Union Chempharma Cephalosporin Shipments, Price, Revenue and Gross profit 2014-2019
3.1.2 Union Chempharma Cephalosporin Business Distribution by Region
3.1.3 Union Chempharma Interview Record
3.1.4 Union Chempharma Cephalosporin Business Profile
3.1.5 Union Chempharma Cephalosporin Product Specification

3.2 NCPC Cephalosporin Business Introduction
3.2.1 NCPC Cephalosporin Shipments, Price, Revenue and Gross profit 2014-2019
3.2.2 NCPC Cephalosporin Business Distribution by Region
3.2.3 Interview Record
3.2.4 NCPC Cephalosporin Business Overview
3.2.5 NCPC Cephalosporin Product Specification

3.3 Qilu Antibiotics Cephalosporin Business Introduction
3.3.1 Qilu Antibiotics Cephalosporin Shipments, Price, Revenue and Gross profit 2014-2019
3.3.2 Qilu Antibiotics Cephalosporin Business Distribution by Region
3.3.3 Interview Record
3.3.4 Qilu Antibiotics Cephalosporin Business Overview
3.3.5 Qilu Antibiotics Cephalosporin Product Specification

3.4 Lupin Pharmaceuticals Cephalosporin Business Introduction
3.5 Hospira Cephalosporin Business Introduction
3.6 Dhanuka Laboratories Cephalosporin Business Introduction


Section 4 Global Cephalosporin Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Cephalosporin Market Size and Price Analysis 2014-2019
4.1.2 Canada Cephalosporin Market Size and Price Analysis 2014-2019
4.2 South America Country
4.2.1 South America Cephalosporin Market Size and Price Analysis 2014-2019
4.3 Asia Country
4.3.1 China Cephalosporin Market Size and Price Analysis 2014-2019
4.3.2 Japan Cephalosporin Market Size and Price Analysis 2014-2019
4.3.3 India Cephalosporin Market Size and Price Analysis 2014-2019
4.3.4 Korea Cephalosporin Market Size and Price Analysis 2014-2019
4.4 Europe Country
4.4.1 Germany Cephalosporin Market Size and Price Analysis 2014-2019
4.4.2 UK Cephalosporin Market Size and Price Analysis 2014-2019
4.4.3 France Cephalosporin Market Size and Price Analysis 2014-2019
4.4.4 Italy Cephalosporin Market Size and Price Analysis 2014-2019
4.4.5 Europe Cephalosporin Market Size and Price Analysis 2014-2019
4.5 Other Country and Region
4.5.1 Middle East Cephalosporin Market Size and Price Analysis 2014-2019
4.5.2 Africa Cephalosporin Market Size and Price Analysis 2014-2019
4.5.3 GCC Cephalosporin Market Size and Price Analysis 2014-2019
4.6 Global Cephalosporin Market Segmentation (Region Level) Analysis 2014-2019
4.7 Global Cephalosporin Market Segmentation (Region Level) Analysis

Section 5 Global Cephalosporin Market Segmentation (Product Type Level)
5.1 Global Cephalosporin Market Segmentation (Product Type Level) Market Size 2014-2019
5.2 Different Cephalosporin Product Type Price 2014-2019
5.3 Global Cephalosporin Market Segmentation (Product Type Level) Analysis

Section 6 Global Cephalosporin Market Segmentation (Industry Level)
6.1 Global Cephalosporin Market Segmentation (Industry Level) Market Size 2014-2019
6.2 Different Industry Price 2014-2019
6.3 Global Cephalosporin Market Segmentation (Industry Level) Analysis

Section 7 Global Cephalosporin Market Segmentation (Channel Level)
7.1 Global Cephalosporin Market Segmentation (Channel Level) Sales Volume and Share 2014-2019
7.2 Global Cephalosporin Market Segmentation (Channel Level) Analysis

Section 8 Cephalosporin Market Forecast 2019-2024
8.1 Cephalosporin Segmentation Market Forecast (Region Level)
8.2 Cephalosporin Segmentation Market Forecast (Product Type Level)
8.3 Cephalosporin Segmentation Market Forecast (Industry Level)
8.4 Cephalosporin Segmentation Market Forecast (Channel Level)

Section 9 Cephalosporin Segmentation Product Type
9.1 First Generation Product Introduction
9.2 Second Generation Product Introduction
9.3 Third Generation Product Introduction
9.4 Fourth Generation Product Introduction

Section 10 Cephalosporin Segmentation Industry
10.1 Oral Clients
10.2 Injection Clients

Section 11 Cephalosporin Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview

Section 12 Conclusion

Chart and Figure
Figure Cephalosporin Product Picture from Union Chempharma
Chart 2014-2019 Global Manufacturer Cephalosporin Shipments (Units)
Chart 2014-2019 Global Manufacturer Cephalosporin Shipments Share
Chart 2014-2019 Global Manufacturer Cephalosporin Business Revenue (Million USD)
Chart 2014-2019 Global Manufacturer Cephalosporin Business Revenue Share
Chart Union Chempharma Cephalosporin Shipments, Price, Revenue and Gross profit 2014-2019
Chart Union Chempharma Cephalosporin Business Distribution
Chart Union Chempharma Interview Record (Partly)
Figure Union Chempharma Cephalosporin Product Picture
Chart Union Chempharma Cephalosporin Business Profile
Table Union Chempharma Cephalosporin Product Specification
Chart NCPC Cephalosporin Shipments, Price, Revenue and Gross profit 2014-2019
Chart NCPC Cephalosporin Business Distribution
Chart NCPC Interview Record (Partly)
Figure NCPC Cephalosporin Product Picture
Chart NCPC Cephalosporin Business Overview
Table NCPC Cephalosporin Product Specification
Chart Qilu Antibiotics Cephalosporin Shipments, Price, Revenue and Gross profit 2014-2019
Chart Qilu Antibiotics Cephalosporin Business Distribution
Chart Qilu Antibiotics Interview Record (Partly)
Figure Qilu Antibiotics Cephalosporin Product Picture
Chart Qilu Antibiotics Cephalosporin Business Overview
Table Qilu Antibiotics Cephalosporin Product Specification
3.4 Lupin Pharmaceuticals Cephalosporin Business Introduction

Chart United States Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart United States Cephalosporin Sales Price ($/Unit) 2014-2019
Chart Canada Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Canada Cephalosporin Sales Price ($/Unit) 2014-2019
Chart South America Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart South America Cephalosporin Sales Price ($/Unit) 2014-2019
Chart China Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart China Cephalosporin Sales Price ($/Unit) 2014-2019
Chart Japan Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Japan Cephalosporin Sales Price ($/Unit) 2014-2019
Chart India Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart India Cephalosporin Sales Price ($/Unit) 2014-2019
Chart Korea Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Korea Cephalosporin Sales Price ($/Unit) 2014-2019
Chart Germany Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Germany Cephalosporin Sales Price ($/Unit) 2014-2019
Chart UK Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart UK Cephalosporin Sales Price ($/Unit) 2014-2019
Chart France Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart France Cephalosporin Sales Price ($/Unit) 2014-2019
Chart Italy Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Italy Cephalosporin Sales Price ($/Unit) 2014-2019
Chart Europe Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Europe Cephalosporin Sales Price ($/Unit) 2014-2019
Chart Middle East Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Middle East Cephalosporin Sales Price ($/Unit) 2014-2019
Chart Africa Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Africa Cephalosporin Sales Price ($/Unit) 2014-2019
Chart GCC Cephalosporin Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart GCC Cephalosporin Sales Price ($/Unit) 2014-2019
Chart Global Cephalosporin Market Segmentation (Region Level) Sales Volume 2014-2019
Chart Global Cephalosporin Market Segmentation (Region Level) Market size 2014-2019
Chart Cephalosporin Market Segmentation (Product Type Level) Volume (Units) 2014-2019
Chart Cephalosporin Market Segmentation (Product Type Level) Market Size (Million $) 2014-2019
Chart Different Cephalosporin Product Type Price ($/Unit) 2014-2019
Chart Cephalosporin Market Segmentation (Industry Level) Market Size (Volume) 2014-2019
Chart Cephalosporin Market Segmentation (Industry Level) Market Size (Share) 2014-2019
Chart Cephalosporin Market Segmentation (Industry Level) Market Size (Value) 2014-2019
Chart Global Cephalosporin Market Segmentation (Channel Level) Sales Volume (Units) 2014-2019
Chart Global Cephalosporin Market Segmentation (Channel Level) Share 2014-2019
Chart Cephalosporin Segmentation Market Forecast (Region Level) 2019-2024
Chart Cephalosporin Segmentation Market Forecast (Product Type Level) 2019-2024
Chart Cephalosporin Segmentation Market Forecast (Industry Level) 2019-2024
Chart Cephalosporin Segmentation Market Forecast (Channel Level) 2019-2024
Chart First Generation Product Figure
Chart First Generation Product Advantage and Disadvantage Comparison
Chart Second Generation Product Figure
Chart Second Generation Product Advantage and Disadvantage Comparison
Chart Third Generation Product Figure
Chart Third Generation Product Advantage and Disadvantage Comparison
Chart Fourth Generation Product Figure
Chart Fourth Generation Product Advantage and Disadvantage Comparison
Chart Oral Clients
Chart Injection Clients

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.